Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Hopledo (carbidopa monohydrate;levodopa) — Zambon SpA
Hopledo, a fixed-dose combination of carbidopa monohydrate and levodopa, has been authorised by the EMA for Parkinson disease. The marketing…
-
EMA approval · 2026-08-20EMA Authorised: Rivastigmine Hexal (rivastigmine) — Hexal AG
Rivastigmine Hexal has been authorised for dementia-related indications in the European market.
-
EMA approval · 2026-08-20EMA Authorised: Rivastigmine Sandoz (rivastigmine) — Sandoz GmbH
EMA authorised rivastigmine Sandoz for dementia indications, including Alzheimer disease and Parkinson disease.
-
EMA approval · 2026-08-20EMA Authorised: Rivastigmine 1 A Pharma (rivastigmine) — 1 A Pharma GmbH
EMA authorises rivastigmine 1 A Pharma for Alzheimer's disease, dementia, and Parkinson's disease.
-
FDA approval · 2026-08-18FDA Tentative Approval: CARBIDOPA AND LEVODOPA — Original Application (DR REDDYS LABS LTD)
Tentative approval for an original application of carbidopa and levodopa tablets (ANDA) by Dr. Reddy's Labs Ltd.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease [NA]
Clinical trial results for ExAblate Transcranial MRgFUS targeting the subthalamic nucleus in Parkinson's disease have been completed with re…
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: Effects of Transcranial Pulse Stimulation in Parkinson's Disease [NA]
Clinical trial results for transcranial pulse stimulation in Parkinson's disease have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients [EARLY_Phase 1]
Early-phase trial comparing midodrine to abdominal compression in autonomic failure patients assessing cardiovascular risk markers.
-
FDA approval · 2026-08-03FDA Tentative Approval: CARBIDOPA AND LEVODOPA — Original Application (BIOCON PHARMA LIMITED)
FDA tentative approval for a generic CARBIDOPA AND LEVODOPA product (BIOCON PHARMA LIMITED) under ANDA 220119.
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Completed trial evaluating cognitive effects of deep brain stimulation in Parkinson disease patients with GBA gene mutations; results posted…
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, and levodopa pharmacokinetics of repeated ND0612 in Parkinson's disease patients.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD) [Phase 2]
Phase 2 clinical trial evaluating the efficacy of pirepemat on falls frequency in patients with Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease [NA]
Finished clinical trial investigating temporal interference stimulation for motor symptoms in Parkinson's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor [NA]
Pilot clinical trial results for the Felix System in patients with Essential Tremor and Parkinson's tremor have been completed with results …
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease [Phase 2]
Phase 2 clinical trial assessing nilotinib in Parkinson's disease with and without dementia; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) [Phase 2]
Phase 2 clinical trial evaluating allogeneic HB-adMSCs for early to moderate Parkinson's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations [Phase 3]
Phase 3 clinical trial evaluating HRG2010 for Parkinson's disease with motor fluctuations has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Brain Networks and Consciousness
Clinical trial results from a terminated study examining brain networks and consciousness; results posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's Disease [NA]
Completed trial investigating the effects of exercise training and ketone ester on muscle strength and cardiovascular response in Parkinson'…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus [EARLY_Phase 1]
An early-phase Phase 1 clinical trial evaluating a chemogenetic gene therapy using an AAV vector for Parkinson's disease, delivered via ster…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease [Phase 2]
This document outlines a Phase 2 study of NEU-411 in companion diagnostic-positive individuals with early Parkinson's disease, plus an open-…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease [Phase 1]
A Phase 1 clinical trial is evaluating PET imaging of cyclooxygenases in neurodegenerative brain diseases, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease [NA]
This clinical trial update discusses a longitudinal study of patterned multichannel vibrotactile stimulation as a treatment for moderate-sta…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
A prospective observational study examining how sociodemographic factors, blood-based biomarkers, and psychiatric symptoms relate across sev…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Open Label Single Arm Prebiotic Pilot Trial SR001 [NA]
An open-label, single-arm prebiotic pilot trial SR001 conducted by Sorridi Therapeutics has completed. The study enrolled participants with …